Non-invasive discrimination of multiple myeloma using label-free serum surface-enhanced Raman scattering spectroscopy in combination with multivariate analysis

Anal Chim Acta. 2022 Jan 25;1191:339296. doi: 10.1016/j.aca.2021.339296. Epub 2021 Nov 17.

ABSTRACT

We report non-invasive discrimination of multiple myeloma (MM) using label-free serum surface-enhanced Raman scattering (SERS) spectroscopy in combination with multivariate analysis. Colloidal silver nano-particles (AgNPs) were used as the SERS substrate. High quality serum SERS spectra were obtained from 53 MM patients and 44 healthy controls (HCs). The SERS spectral differences demonstrated variation of relative concentrations of biomolecules in the serum of MM patients in comparison to HCs. Multivariate analysis methods, including principal component analysis (PCA), linear discriminant analysis (LDA), and support vector machine (SVM), were used to build discrimination models for MM. Leave-one-out cross-validation (LOOCV) was used to evaluate the performances of the models, in terms of accuracy, sensitivity, specificity, and area under the receiver operating characteristic curves (AUC). Using the SVM model, the accuracy for discrimination of MM was achieved as 78.4%, and the corresponding sensitivity, specificity, and AUC values were 0.830, 0.727, and 0.840, respectively. The results show that the serum SERS in combination with multivariate analysis could be a fast, non-invasive, and cost-effective technique for discrimination of MM.

PMID:35033255 | DOI:10.1016/j.aca.2021.339296